Roche Holding | ROG - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
AbbVie USD 746M 101M 2026-06
Alcon AG USD 53M 1000K 2026-06
Amgen USD 95.64B 94.98B 2026-06
AstraZeneca USD 371M 31M 2026-09
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 403M 4M 2026-09
Eli Lilly USD 316M 201.3M 2026-09
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 83M 4M 2026-06
Genmab DKK 139M 129M 2026-06
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Lonza CHF 84M 14M 2025-06
Merck EUR 137M 33M 2026-06
Merck USD 525M 46M 2026-06
Novartis USD 462M 119M 2026-06
Orion EUR 300K 400K 2026-09
Pfizer USD 667M 4M 2026-06
Philips EUR 83M 26M 2026-03
Recordati EUR 22.13M 1.43M 2025-12
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
UCB EUR 49M 29M 2025-12